Whitepapers - Pharmaphorum

Latest White papers

in Whitepapers

Pricing and Market Access Outlook 2018
March 5, 2018 Share
X
Pricing and Market Access Outlook 2018
https://pharmaphorum.com/market-access-2/debates-insight-market-access/pricing-market-access-outlook-2018/
in Whitepapers

Definitive Guide to Global Transparency Regulations for the Life Sciences
November 13, 2017 Share
X
Definitive Guide to Global Transparency Regulations for the Life Sciences
https://pharmaphorum.com/customer-engagement/debates-insight-customer-engagement/transparency-regulations-life-sciences/
in

Touchpoint optimisation: time for multichannel marketing to reconnect the brand story and the customer
October 24, 2017 Share
X
Touchpoint optimisation: time for multichannel marketing to reconnect the brand story and the customer
https://pharmaphorum.com/customer-engagement/debates-insight-customer-engagement/touchpoint-optimisation-time-multichannel-marketing-reconnect-brand-story-customer/
in

Connecting the dots: Analysing the power of customer relationships
September 18, 2017 Share
X
Connecting the dots: Analysing the power of customer relationships
https://pharmaphorum.com/customer-engagement/debates-insight-customer-engagement/power-customer-relationships/
in Whitepapers

Pharma brand strategy: Transforming lives with rich insight
April 23, 2018 Share
X
Pharma brand strategy: Transforming lives with rich insight
https://pharmaphorum.com/customer-engagement/debates-insight-customer-engagement/pharma-brand-strategy-transforming-lives-with-rich-insight/
in Whitepapers

Standing on the cusp of something great: How real-world data is poised to transform cancer care
March 19, 2018 Share
X
Standing on the cusp of something great: How real-world data is poised to transform cancer care
https://pharmaphorum.com/market-access-2/debates-insight-market-access/standing-cusp-something-great-real-world-data-poised-transform-cancer-care/
in Whitepapers

Pricing and Market Access Outlook 2018
March 5, 2018 Share
X
Pricing and Market Access Outlook 2018
https://pharmaphorum.com/market-access-2/debates-insight-market-access/pricing-market-access-outlook-2018/
in Whitepapers

Definitive Guide to Global Transparency Regulations for the Life Sciences
November 13, 2017 Share
X
Definitive Guide to Global Transparency Regulations for the Life Sciences
https://pharmaphorum.com/customer-engagement/debates-insight-customer-engagement/transparency-regulations-life-sciences/

Pricing and Market Access Outlook 2018

This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models

Pricing and Market Access Outlook 2018

https://pharmaphorum.com/market-access-2/debates-insight-market-access/pricing-market-access-outlook-2018/

Definitive Guide to Global Transparency Regulations for the Life Sciences

In 2015, Zephyr Health released its first ‘Definitive Guide to Global Life Sciences Transparency Regulations’, outlining the

Definitive Guide to Global Transparency Regulations for the Life Sciences

https://pharmaphorum.com/customer-engagement/debates-insight-customer-engagement/transparency-regulations-life-sciences/

See all

More White papers

Seizing the potential of commercial outsourcing in the pharmaceutical sector

The power and potential of outsourcing has long been recognised as a core enabler of business growth. Yet

Seizing the potential of commercial outsourcing in the pharmaceutical sector

https://pharmaphorum.com/whitepapers/seizing-potential-commercial-outsourcing-pharmaceutical-sector/

Pricing and market access – facts versus fiction

‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.

Pricing and market access – facts versus fiction

https://pharmaphorum.com/market-access-2/debates-insight-market-access/pricing-market-access-facts-versus-fiction/

Healthcare in the Digital Age

A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.

Healthcare in the Digital Age

https://pharmaphorum.com/digital-health/debates-insight-digital-health/healthcare-digital-age/

Planning, Executing, and Monitoring: The Three Pillars of an Effective Marketing Campaign

No longer are physicians the sole concern for the life sciences’ sales and marketing function. Today, as a

Planning, Executing, and Monitoring: The Three Pillars of an Effective Marketing Campaign

https://pharmaphorum.com/transversal-categories/sales-and-marketing/planning-executing-monitoring-three-pillars-effective-marketing-campaign/

Health wearables: Turning hype into value-added services

The needs of patients continue to be weighed against the burgeoning costs of healthcare. Against this backdrop, life

Health wearables: Turning hype into value-added services

https://pharmaphorum.com/digital-health/debates-insight-digital-health/health-wearables-turning-hype-value-added-services/

The hype and the hope: The journey from consumer to medical-grade wearables

Can medical-grade wearables provide efficient, patient-friendly, and cost-effective solutions in an ever-changing healthcare environment?

The hype and the hope: The journey from consumer to medical-grade wearables

https://pharmaphorum.com/digital-health/debates-insight-digital-health/hype-hope-journey-consumer-medical-grade-wearables/

Big data in Life Sciences: the time for strategy is now

The ability to extract insights from big data is quickly becoming a key factor for competitive advantage in

Big data in Life Sciences: the time for strategy is now

https://pharmaphorum.com/market-access-2/debates-insight-market-access/life-sciences-brands-need-big-data-strategy-now/

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

https://pharmaphorum.com/patients/debates-insight-patients/patient-centricity-identifying-boehringer-ingelheim-uk-can-better/

From ideals to execution: the reality of patient-centricity in 2016 and what’s next for pharma

‘Patient-centricity’ is one of the buzzwords of the life sciences industry. It demonstrates a shift in the way

From ideals to execution: the reality of patient-centricity in 2016 and what’s next for pharma

https://pharmaphorum.com/patients/debates-insight-patients/ideals-execution-reality-patient-centricity-2016-whats-next-pharma/

Transforming compliance with technology

The need for increased transparency is placing additional compliance pressure on the Life Sciences industry, especially on

Transforming compliance with technology

https://pharmaphorum.com/customer-engagement/debates-insight-customer-engagement/insightfully-compliant-how-technology-is-transforming-relationships-between-medical-affairs-and-healthcare-providers/

See all

Search

Advanced Search

Trending

Latest White papers

More White papers